ANABのPER（株価収益率）は？

Anaptysbio Inc（ANAB）は現在PER 24.55倍で取引されています。

ANABのROE（自己資本利益率）は？

Anaptysbio IncのROEは-210.14%です。

ANABの配当利回りは？

Anaptysbio Incの配当利回りは0.00%です。

ANABの品質スコア（Quality Score）は？

当社のAIはANABの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

ANABは今が買い時ですか？

当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

ANABはどのセクターに属しますか？

Anaptysbio IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

ANAB (NASDAQ) 株価分析 | ANAPTYSBIO INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

ANAB AI Analysis Summary

Our AI summary for ANAB: Anaptysbio Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 24.55, ROE of -210.14%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ANAB

Anaptysbio Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 82

USD 55.13

1.47 (2.74%) Day Change

Watchlist Portfolio Compare Chart

24.55

P/E

0.17

D/E

-210.1%

ROE

-8.1%

ROA

0.00%

Div Yield

-0.99

PEG

ANAPTYSBIO INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 55.13 Price 1.47 (2.74%) Day Change	NEWS SCORE: 82

ANAB, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	82
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	55.13
PBV / Sector	124.64 / 44,022.72
Earning Per Share	-0.93

PE / Sector	24.55 / 19.17
PEG or PE/Growth / Sector	-0.99 / 1.24
Average 1M Daily Value	41.88 M GREAT
Average 1W Daily Value	29.96 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-11.53 / 98.24
NPM Average (%) / Sector	-476.25 / -1,697.63
NPM Change Average (%) / Sector	-24.80 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-8.13 / 185,260.96
ROA Average (%) / Sector	-19.81 / 36,684.70
ROA Change Average (%) / Sector	22.59 / 422,221.66 GREAT
ROE (%) / Sector	-210.14 / 243,762.23
ROE Average (%) / Sector	-137.09 / 48,758.47
ROE Change Average (%) / Sector	174.20 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

登録情報

Analyze Date	2026-08-05 07:59:49
Symbol	ANAB
Name	ANAPTYSBIO INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	29.61 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,588.79 / 9,586.08

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801

Phone: 858 362 6295

Website: https://www.anaptysbio.com

Employees: 104

Sector: Healthcare >> Biotechnology

Description: AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.